+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival



Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival



Cancer 67(2): 372-379



Between January 1986 and September 1988, 75 patients with locally advanced cervical carcinoma (International Federation of Gynecology and Obstetrics [FIGO] Stages IB-III) received three courses of neoadjuvant chemotherapy (NAC), including cisplatin, bleomycin, and methotrexate (PBM). Fifteen percent of patients achieved a complete response (CR) and 68% a partial response (PR). Pretreatment characteristics were analyzed for response to NAC. Significantly lower response rates were found in patients with tumor size more than 5 cm in diameter and bilateral parametrial involvement to the pelvic side wall. None of the biological parameters studied was related to chemoresponsiveness. Patients achieving CR or PR had a significantly improved 3-year survival rate compared with those who did not respond. After NAC, radical surgery was possible in all responding patients. The median number of lymph nodes removed was 60. A lower than expected incidence of lymph node metastases was detected. None of the clinical and pathologic features considered was significantly correlated with the lymph node status. Twelve of the 62 operated patients had disease recurrence. Pathologic parametrial involvement and cervical infiltration equal to or deeper than 5 mm were found to be significant prognostic factors for recurrence. A 3-year, disease-free survival of 89%, 73%, and 43% for Stage IB-IIA, IIB, and III, respectively, was found. Among the operated patients these rates increased to 100%, 81%, and 66% for Stage IB-IIA, IIB, and III, respectively. A prospective randomized trial comparing NAC and surgery with radiotherapy alone is in progress.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 040779907

Download citation: RISBibTeXText

PMID: 1702348

DOI: 10.1002/1097-0142(19910115)67:2<372::aid-cncr2820670210>3.0.co;2-5


Related references

Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up. Medical Oncology 33(10): 110, 2016

Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. European Journal Of Cancer. 34(3): 341-346,., 1998

Survival benefits of neoadjuvant chemotherapy followed by radical surgery versus radiotherapy in locally advanced chemoresistant cervical cancer. Journal of Korean Medical Science 21(4): 683-689, 2006

Prognostic factors for locally advanced cervical cancer treated with neoadjuvant intravenous and transuterine arterial chemotherapy followed by radical hysterectomy. International Journal of Gynecological Cancer 23(8): 1470-1475, 2013

Impact of Blood Transfusions on Survival of Locally Advanced Cervical Cancer Patients Undergoing Neoadjuvant Chemotherapy Plus Radical Surgery. International Journal of Gynecological Cancer 27(3): 514-522, 2017

Neoadjuvant radiotherapy plus radical surgery for locally advanced stage III/IV oral cancer: Analysis of prognostic factors affecting overall survival. Oral Oncology 60: 1-7, 2016

Prognostic factors of survival in pathologic incomplete response patients with locally advanced breast cancer after neoadjuvant chemotherapy. Cell Biochemistry and Biophysics 71(2): 1181-1190, 2015

Analysis of adjuvant therapy for recurrent medium risk factors in young patients with locally advanced cervical cancer after neoadjuvant chemotherapy followed by radical surgery. Gynecologic Oncology 149: 77-78, 2018

Safety and Efficacy of Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Radical Surgery Alone in Locally Advanced Cervical Cancer Patients. International Journal of Gynecological Cancer 26(4): 722-728, 2016

Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer. Gynecologic Oncology 125(supp-S1): 0-0, 2012

Neoadjuvant chemotherapy prior to radical surgery or radiotherapy for locally advanced cervical cancer. Gynecologic Oncology 52(1): 148, 1994

The role of neoadjuvant chemotherapy followed by radical surgery in the treatment of locally advanced cervical cancer. European Journal of Gynaecological Oncology 24(6): 467-470, 2003

Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Gynecologic Oncology 82(1): 88-93, 2001

Neoadjuvant chemotherapy plus radical surgery in locally advanced cervical cancer during pregnancy: a case report. American Journal of Obstetrics and Gynecology 197(4): E5-E6, 2007

Ovarian preservation in locally advanced cervical cancer undergoing neoadjuvant chemotherapy and radical surgery. Minerva Ginecologica 70(4): 357-363, 2018